Progress in purifying the opiate receptor, a goal essential to understanding both its chemical nature and function, has been slow. Current evidence suggests that this may be due to the fact that the opiate receptor is a complex, multi-component system, containing differently selective binding sites, regulatory molecules, effector system, closely associated with a proper membrane lipid environment. Solubilization of membrane would be expected to dissociate these components, whose integration may be necessary for full expression of opiate binding as well as biologic activity. We accordingly propose to isolate different receptor components and test the ability of combinations of them to exhibit opiate binding, and, when reconstituted back into the membrane, opiate-mediated function, (e.g., inhibition of adenylate cyclase). The reconstitution step serves as an ultimate test of the integrity of the solubilized receptor and because of its multicomponent nature, may be necessary for full expression of binding activity. In isolation of opiate receptors, our approaches involve detergent solubilization, isolation of binding components by affinity chromatography, and receptor reconstitution. The latter emphasis on both reconstitution of binding and functional activities. Reconstitution methods used include dialysis, sonication and fusion with genetic mutants of S49 lymphoma cells. We will also use a newer approach, solubilizing with the natural detergent lysophosphatidylcholine and reconstituting the membrane by its enzymatic conversion to phosphatidylcholine. This method for the reconstitution of brain membrane, developed in our laboratory, by itself should be very important in the studies of general membrane structure and function. To make our approach thorough, we will also attempt to isolate receptor molecules through the use of monoclonal antibodies, using partially purified receptor to develop the antibodies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA001583-08
Application #
3206962
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1984-05-01
Project End
1987-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
8
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Hwang, Cheol Kyu; Wagley, Yadav; Law, Ping-Yee et al. (2017) Phosphorylation of poly(rC) binding protein 1 (PCBP1) contributes to stabilization of mu opioid receptor (MOR) mRNA via interaction with AU-rich element RNA-binding protein 1 (AUF1) and poly A binding protein (PABP). Gene 598:113-130
Song, Kyu Young; Choi, Hack Sun; Law, Ping-Yee et al. (2017) Post-Transcriptional Regulation of the Human Mu-Opioid Receptor (MOR) by Morphine-Induced RNA Binding Proteins hnRNP K and PCBP1. J Cell Physiol 232:576-584
Wagley, Yadav; Law, Ping-Yee; Wei, Li-Na et al. (2017) Epigenetic Activation of ?-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1. Mol Pharmacol 91:357-372
Hwang, Cheol Kyu; Wagley, Yadav; Law, Ping-Yee et al. (2015) Analysis of epigenetic mechanisms regulating opioid receptor gene transcription. Methods Mol Biol 1230:39-51
Wei, Li-Na; Dmintrovsky, Ethan (2015) Retinoids are back. FASEB J 29:1131-5
Macias Konstantopoulos, Wendy L; Dreifuss, Jessica A; McDermott, Katherine A et al. (2014) Identifying patients with problematic drug use in the emergency department: results of a multisite study. Ann Emerg Med 64:516-25
Feng, X; Wu, C-Y; Burton, F H et al. (2014) ?-arrestin protects neurons by mediating endogenous opioid arrest of inflammatory microglia. Cell Death Differ 21:397-406
Wagley, Yadav; Hwang, Cheol Kyu; Lin, Hong-Yiou et al. (2013) Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-?B activation in neuronal and non-neuronal cells. Biochim Biophys Acta 1833:1476-88
Wu, Qifang; Hwang, Cheol Kyu; Zheng, Hui et al. (2013) MicroRNA 339 down-regulates ?-opioid receptor at the post-transcriptional level in response to opioid treatment. FASEB J 27:522-35
Song, Kyu Young; Choi, Hack Sun; Law, Ping-Yee et al. (2013) Vimentin interacts with the 5'-untranslated region of mouse mu opioid receptor (MOR) and is required for post-transcriptional regulation. RNA Biol 10:256-66

Showing the most recent 10 out of 52 publications